HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57

from Biotech Blueprint · host Katerina Roznik

Subscribe for free HERE. Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA reform efforts. Listen to the biggest news from biotech and pharma this week (June 13–19, 2025).

Episode metadata supplied by the publisher feed · Published Jun 20, 2025

Embed this episode

Attribution link and audio player

Ready to play

HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57

0:00 7:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Research in Action Oracle Corporation "Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in connecting clinical research with patient care. Hear insightful conversations with scientists, clinicians, and leaders from pharma, biotech, and health.

Frequently Asked Questions

How long is this episode of Biotech Blueprint?

This episode is 7 minutes long.

When was this Biotech Blueprint episode published?

This episode was published on June 20, 2025.

Can I download this Biotech Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!